Showing results (451-460 of 480) with videos related to

Sort By:
Pageof 48
BMC Health Services Research|October 26, 2019
Patient and provider perspectives on how trust influences maternal vaccine acceptance among pregnant women in KenyaStacy W Nganga, Nancy A Otieno, Maxwell Adero, et al.
JMIR Research Protocols|January 12, 2021
Reducing Ethnic and Geographic Inequities to Optimise New Zealand Stroke Care (REGIONS Care): Protocol for a Nationwide Observational StudyAnnemarei Ranta, Stephanie Thompson, Matire Louise Ngarongoa Harwood, et al.
Neurology|May 27, 2022
Geographic Disparities in Stroke Outcomes and Service Access: A Prospective Observational StudyStephanie G Thompson, P Alan Barber, John H Gommans, et al.
American Journal of Preventive Cardiology|June 3, 2024
Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics modelStephen T Vernon, Stuart Brentnall, Danielle J Currie, et al.
Trials|June 11, 2015
Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trialGraham Devereux, Seonaidh Cotton, Peter Barnes, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 6, 2023
Ethnic differences in stroke outcomes in Aotearoa New Zealand: A national linkage studyHayley J Denison, Marine Corbin, Jeroen Douwes, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 24, 2025
Rationale and Design of the Alpha-1 Biomarkers Consortium StudyMonica P Goldklang, Cheryl Pirozzi, Igor Barjaktarevic, et al.
JAMA|October 17, 2018
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Shona Fielding, et al.
Health Technology Assessment (Winchester, England)|July 26, 2019
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCTGraham Devereux, Seonaidh Cotton, Shona Fielding, et al.
Human Vaccines & Immunotherapeutics|June 27, 2018
The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: A multi-centre, double-blind, randomised controlled trialKerry-Ann F O'Grady, Anne B Chang, Allan Cripps, et al.
Pageof 48